ACACIA PHARMA Trademark

Trademark Overview


On Tuesday, January 6, 2015, a trademark application was filed for ACACIA PHARMA with the United States Patent and Trademark Office. The USPTO has given the ACACIA PHARMA trademark a serial number of 79173176. The federal status of this trademark filing is REGISTERED as of Tuesday, June 21, 2016. This trademark is owned by Acacia Pharma Limited. The ACACIA PHARMA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Sanitary preparations for medical purposes; pharmaceutical preparations for the management of post-operative nausea and vomiting (PONV); pharmaceutical preparations for the management of chemotherapy induced nausea and vomiting (CINV); pharmaceutical preparations for the management of xerostomia (dry mouth); pharmaceutical preparations for the management of cancer cachexia; pharmaceutical preparations for the management of cancer treatment side effects; pharmaceutical preparations for the management of side effects of surgery; pharmaceutical preparations for the management of cancer side effects; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations associated with surgery

Scientific and technological services and research and design relating thereto, namely, scientific research, analysis and testing in the field of repurposing existing drugs for new therapeutic uses; pharmaceutical and veterinary product evaluation, development and testing services; pharmaceutical research, inspection and testing; medical and pharmaceutical research services; scientific research for medical purposes in the area of cancerous disease; pharmaceutical research, inspection, testing, development and evaluation of pharmaceutical and veterinary preparations, sanitary preparations for medical purposes, dietetic food and substances adapted for medical or veterinary use, pharmaceutical preparations for the management of post-operative nausea and vomiting (PONV), pharmaceutical preparations for the management of chemotherapy induced nausea and vomiting (CINV), pharmaceutical preparations for the management of xerostomia (dry mouth), pharmaceutical preparations for the management of...
acacia pharma

General Information


Serial Number79173176
Word MarkACACIA PHARMA
Filing DateTuesday, January 6, 2015
Status700 - REGISTERED
Status DateTuesday, June 21, 2016
Registration Number4980399
Registration DateTuesday, June 21, 2016
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 5, 2016

Trademark Statements


Description of MarkThe mark consists of the stylized wording "ACACIA PHARMA" and the stylized design of an irregular oval shape with a block positioned above it that has a pointed end at the left edge and a flat end at the right edge. The design and word "ACACIA" are in black and the word "PHARMA" is in blue. The color white represents background, outlining, shading, and/or transparent areas and is not part of the mark.
Goods and ServicesSanitary preparations for medical purposes; pharmaceutical preparations for the management of post-operative nausea and vomiting (PONV); pharmaceutical preparations for the management of chemotherapy induced nausea and vomiting (CINV); pharmaceutical preparations for the management of xerostomia (dry mouth); pharmaceutical preparations for the management of cancer cachexia; pharmaceutical preparations for the management of cancer treatment side effects; pharmaceutical preparations for the management of side effects of surgery; pharmaceutical preparations for the management of cancer side effects; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations associated with surgery
Indication of Colors claimedThe color(s) black and blue is/are claimed as a feature of the mark.
NOT AVAILABLE"PHARMA"
Goods and ServicesScientific and technological services and research and design relating thereto, namely, scientific research, analysis and testing in the field of repurposing existing drugs for new therapeutic uses; pharmaceutical and veterinary product evaluation, development and testing services; pharmaceutical research, inspection and testing; medical and pharmaceutical research services; scientific research for medical purposes in the area of cancerous disease; pharmaceutical research, inspection, testing, development and evaluation of pharmaceutical and veterinary preparations, sanitary preparations for medical purposes, dietetic food and substances adapted for medical or veterinary use, pharmaceutical preparations for the management of post-operative nausea and vomiting (PONV), pharmaceutical preparations for the management of chemotherapy induced nausea and vomiting (CINV), pharmaceutical preparations for the management of xerostomia (dry mouth), pharmaceutical preparations for the management of cancer cachexia, pharmaceutical preparations for the management of cancer treatment side effects, pharmaceutical preparations for the management of side effects of surgery, pharmaceutical preparations for the management of cancer side effects, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations associated with surgery; information, advisory and consultancy services relating to the aforementioned services

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 2, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, October 2, 2015
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAcacia Pharma Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameAcacia Pharma Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameAcacia Pharma Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Thursday, October 1, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, October 2, 2015ASSIGNED TO EXAMINER
Tuesday, October 6, 2015APPLICATION FILING RECEIPT MAILED
Wednesday, February 10, 2016ASSIGNED TO LIE
Friday, October 2, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 7, 2015NON-FINAL ACTION WRITTEN
Thursday, October 8, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, October 8, 2015REFUSAL PROCESSED BY MPU
Thursday, October 8, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, October 24, 2015REFUSAL PROCESSED BY IB
Friday, February 5, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 16, 2016NOTICE OF PUBLICATION
Thursday, October 20, 2016FINAL DISPOSITION PROCESSED
Thursday, February 11, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 11, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 11, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 23, 2016ASSIGNED TO LIE
Tuesday, March 1, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, April 5, 2016PUBLISHED FOR OPPOSITION
Tuesday, June 21, 2016REGISTERED-PRINCIPAL REGISTER
Wednesday, September 21, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, October 20, 2016FINAL DISPOSITION NOTICE SENT TO IB
Friday, November 11, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, July 30, 2020NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, January 12, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, January 12, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 12, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 12, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 12, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, January 21, 2022NEW REPRESENTATIVE AT IB RECEIVED
Friday, February 18, 2022NEW REPRESENTATIVE AT IB RECEIVED
Friday, August 5, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 5, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, August 5, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 25, 2023NEW REPRESENTATIVE AT IB RECEIVED
Thursday, October 31, 2024INTERNATIONAL REGISTRATION RENEWED
Wednesday, October 11, 2023LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Monday, June 6, 2022TEAS SECTION 71 RECEIVED
Friday, August 5, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, September 3, 2022NEW REPRESENTATIVE AT IB RECEIVED
Sunday, June 4, 2023RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED